Viracta Therapeutics (VIRX) Q1 2023 Earnings

8MayConfirmed
Aug 22
Nov 22
Q4 2022
Q1 2023
-0.47
-0.4
-0.34
-0.27

Details

Expected EPS
-0.31
Actual EPS
-0.32
Surprise EPS
-0.01
Surprise Percent
+3.23%

Description

Viracta Therapeutics (VIRX) has reported earnings of -0.32 per share for Q1 2023.

0 Comments

Share your thoughts